21 CFR Part 312 Investigational New Drug Application
Title:
21 CFR Part 312 Investigational New Drug Application
Origin/Publisher:
US Federal Register
Document Type:
Code of Federal Regulations
Content:
This part contains procedures governing the use of investigational new products including the submission to, and review by, the FDA.